VIEW PRESS RELEASE 05 MAR 2014: Valley View, OH – Great Lakes NeuroTechnologies announced today they have received a new allowance of claims from the U.S. Patent Office, the company’s fourth in the past eight months focused on technology for…
Blog Archives
PRESS RELEASE: Great Lakes NeuroTechnologies Continues Intellectual Property Growth As New Patent Claims Focus On Parkinson’s Device Accuracy And Sensitivity
Tagged with: assessment, bradykinesia, clinical trials, company, dbs, deep brain stimulation, development, dyskinesia, gait, growth, kinesia, movement disorders, neuroprotective, parkinson's disease, patent, pd, rigidity, telemedicine, tremor
PRESS RELEASE: GLNT Secures Allowance Of Patent For Controlling Parkinson’s Therapy In Response To Symptoms
VIEW PRESS RELEASE [PDF] 04 FEB 2014: Valley View, OH – Great Lakes NeuroTechnologies announced today they have received another allowance of claims from the U.S. Patent Office. The application covers a system and method of controlling Parkinson’s therapy in…
Another Patent Allowance for GLNT
We’ve just received another patent allowance – our fourth in the past eight months – focused on technology for Parkinson’s disease diagnostics and treatment. This latest allowed patent claims cover technology that meets a critical market need for greater sensitivity…
PRESS RELEASE: GLNT Receives $1.5 Million to Further Technology for Assessing Bradykinesia Response to Novel Therapies in Parkinson’s Disease
VIEW PRESS RELEASE [PDF] 08 AUG 2012: Valley View, OH – Great Lakes NeuroTechnologies [ http://www.glneurotech.com ] announced today that they have received $1.5 million in funding to commercialize a technology for Parkinson’s disease (PD) patients that will better assess…
Tagged with: brady kinesia, company, dbs, deep brain stimulation, development, funding, growth, homeview, parkinson's disease, pd, pharmaceutical, stroke, symptom response, telemedicine, therapy, treatment, tremor, updrs
PRESS RELEASE: GLNT Launches Parkinson’s Technology In Europe For Quantitative Assessments In Telemedicine
VIEW PRESS RELEASE [PDF] 13 JUN 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today that they are launching the latest version of their medical device technology for assessing Parkinson’s disease next week at the Movement Disorders Society Congress…
Tagged with: clinical trial, clinical trials, company, dbs, deep brain stimulation, development, efficacy, growth, homeview, mds, motion sensor, parkinson's disease, pd, tablet, technology, telemedicine, web app
PRESS RELEASE: GLNT Issued Patent Claims For Technology To Assess Parkinson’s Disease
VIEW PRESS RELEASE [PDF] 6 JUN 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today that the U.S. Patent Office has issued claims under patent number 8,187,209 covering their Movement Disorder Monitoring System and Method for quantitative assessment of…
PRESS RELEASE: GLNT Secures Over $4.5 Million in Funding to Fuel New Product Development for Parkinson’s Disease and Neuroscience Education
VIEW PRESS RELEASE [PDF] April 24, 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today they have secured over $4.5 million is funding for new product development. The funding includes three new projects sponsored by the National Institutes of…
Tagged with: balance, biomedical engineering, bme, company, data analysis, dbs, dcs, deep brain stimulation, development, direct current stimulation, education, funding, gait, growth, learning, motion sensor, neurotechnology, nih, parkinson's disease, physiological monitor, ridigity, sbir, signal acquisition, teaching, telemedicine, tremor, wireless physiology
PRESS RELEASE: Cleveland Medical Devices Inc. spins off Great Lakes NeuroTechnologies
VIEW PRESS RELEASE [PDF] Cleveland, OH – March 23, 2011 – Cleveland Medical Devices Inc. (CMDI) has announced the formation of Great Lakes NeuroTechnologies (www.GLNeuroTech.com), a spin-off company which has acquired the rights to develop, market, and manufacture clinical motor…
PRESS RELEASE: FROST & SULLIVAN LAUDS CLEVEMED FOR KINESIA™, A REVOLUTIONARY MOBILITY DISORDER MONITORING SYSTEM
VIEW PRESS RELEASE [PDF] Palo Alto, Calif. – March 12, 2008 – Based on its recent analysis of the mobility disorder monitoring systems market, Frost & Sullivan recognizes Cleveland Medical Devices Inc. (CleveMed) with the 2008 North American Product Innovation…
Tagged with: bradykinesia, company, development, essential tremor, et, growth, kinesia, motor assessment, motor symptoms, parkinson's disease, pd
PRESS RELEASE: CLEVEMED’S KINESIA DEVICE AWARDED NEUROTECH BUSINESS REPORT’S “GOLD ELECTRODE AWARD” FOR BEST NEW PRODUCT
VIEW PRESS RELEASE [PDF] CLEVELAND, OHIO (Nov. 20, 2007) – The Neurotech Business Report announced Friday, October 26 th at the 2007 Neurotech Leaders Forum in Newport Beach, CA that Cleveland Medical Devices Inc.’s (CleveMed) Kinesia TM Quantitative Motor Assessment…
Tagged with: assessment, company, development, growth, kinesia, movement disorder, neuroscience, wireless